Advanced Search

Technical Analysis for JNCE - Jounce Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 7.24 -3.85% -0.29
JNCE closed down 3.85 percent on Friday, January 17, 2020, on 38 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
3 Watchers
Watchlist Portfolio

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical JNCE trend table...
Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Oversold Stochastic Weakness -3.85%
Stochastic Buy Signal Bullish -5.85%
Oversold Stochastic Weakness -5.85%
50 DMA Support Bullish -2.69%
Bullish Engulfing Bullish -2.69%
1,2,3 Pullback Bullish Bullish Swing Setup -2.69%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.69%
Lower Bollinger Band Walk Weakness -2.69%
Outside Day Range Expansion -2.69%
Older EOD signals for JNCE ...
View Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
JNCE Chart by TradingView
Basic chart:

Profile

Jounce Therapeutics, Inc. is a clinical-stage immunotherapy company. It engaged in developing therapies which enable the immune system to attack tumors. The Company's lead product candidate, JTX-2011, is a clinical-stage monoclonal antibody that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of certain T cells found in a range of solid tumors. It also developing JTX-4014 for use in future combinations with JTX-2011, as well as for use in combination with other future product candidates. Jounce Therapeutics, Inc. is based in Cambridge, United States.
Biotechnology Life Sciences Biology Natural Sciences Immunology Immunotherapy Solid Tumors Immune System Monoclonal Antibodies

Is JNCE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Jan 17 Jounce Therapeutics (JNCE) Investor Presentation - Slideshow
Jan 9 Jounce Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference
Jan 7 Is Jounce Therapeutics, Inc. (NASDAQ:JNCE) Worth US$7.9 Based On Its Intrinsic Value?
Dec 20 Is Jounce Therapeutics (JNCE) Stock Outpacing Its Medical Peers This Year?
Dec 20 Did Hedge Funds Drop The Ball On Jounce Therapeutics, Inc. (JNCE)?
Dec 19 Jounce Therapeutics to Present New Data on a Potential Predictive Biomarker from the Vopratelimab ICONIC Trial at the 2020 ASCO-SITC Clinical Immuno-Oncology Symposium Annual Meeting
Dec 19 ImmunoGen (IMGN) Looks Good: Stock Adds 7.6% in Session
Dec 19 5 Russell 2000 Stocks That Crushed the Index This Year
Dec 18 Pacira's Late-Stage Study on Exparel Label Expansion Positive
Dec 13 Assertio to Divest Shingles Pain Drug to Alvogen for $127.5M
See more JNCE news...

Indicators

Indicator Value
52 Week High 10.0
52 Week Low 2.79
Average Volume 858,237
200-Day Moving Average 5.05
50-Day Moving Average 6.97
20-Day Moving Average 8.03
10-Day Moving Average 7.58
Average True Range 0.67
ADX 25.81
+DI 25.09
-DI 21.84
Chandelier Exit (Long, 3 ATRs ) 8.00
Chandelier Exit (Short, 3 ATRs ) 8.73
Upper Bollinger Band 9.09
Lower Bollinger Band 6.97
Percent B (%b) 0.13
BandWidth 26.30
MACD Line 0.03
MACD Signal Line 0.23
MACD Histogram -0.1953
Fundamentals Value
Market Cap 232.8 Million
Num Shares 32.2 Million
EPS 0.03
Price-to-Earnings (P/E) Ratio 241.33
Price-to-Sales 5.66
Price-to-Book 2.51
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.92
Resistance 3 (R3) 7.98 7.82 7.80
Resistance 2 (R2) 7.82 7.65 7.79 7.76
Resistance 1 (R1) 7.53 7.54 7.45 7.47 7.73
Pivot Point 7.37 7.37 7.33 7.34 7.37
Support 1 (S1) 7.08 7.20 7.00 7.02 6.75
Support 2 (S2) 6.92 7.09 6.89 6.72
Support 3 (S3) 6.63 6.92 6.68
Support 4 (S4) 6.57